Next Article in Journal
Polyphosphate during the Regreening of Chlorella vulgaris under Nitrogen Deficiency
Previous Article in Journal
Evaluating Osteogenic Potential of Ligamentum Flavum Cells Cultivated in Photoresponsive Hydrogel that Incorporates Bone Morphogenetic Protein-2 for Spinal Fusion
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Dangerous Liaisons: Caspase-11 and Reactive Oxygen Species Crosstalk in Pathogen Elimination

by
JoAnn Simone Roberts
1,* and
Ӧzlem Yilmaz
2,3
1
Department of Oral Biology, University of Florida, Gainesville, FL 32610, USA
2
Department of Periodontology, University of Florida, P.O. Box 100434, Gainesville, FL 32610, USA
3
Emerging Pathogens Institute, University of Florida, P.O. Box 100434, Gainesville, FL 32610, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2015, 16(10), 23337-23354; https://doi.org/10.3390/ijms161023337
Submission received: 1 September 2015 / Revised: 23 September 2015 / Accepted: 24 September 2015 / Published: 28 September 2015
(This article belongs to the Section Biochemistry)

Abstract

:
Recently, the focus of murine caspase-11 and human orthologs caspase-4, -5 research has been on their novel function to induce noncanonical inflammasome activation in direct response to Gram-negative bacterial infection. On the other hand, a new role in anti-bacterial autophagy has been attributed to caspase-11, -4 and -5, which currently stands largely unexplored. In this review, we connect lately emerged evidence that suggests these caspases have a key role in anti-bacterial autophagy and discuss the growing implications of a danger molecule—extracellular ATP—and NADPH oxidase-mediated ROS generation as novel inducers of human caspase-4, -5 signaling during infection. We also highlight the adeptness of persistent pathogens like Porphyromonas gingivalis, a Gram-negative anaerobe and successful colonizer of oral mucosa, to potentially interfere with the activated caspase-4 pathway and autophagy. While, the ability of caspase-4, -5 to promote autophagolysosomal fusion is not well understood, the abundance of caspase-4 in skin and other mucosal epithelial cells implies an important role for caspase-4 in mucosal defense, supporting the view that caspase-4, -5 may play a non-redundant part in innate immunity. Thus, this review will join the currently disconnected cutting-edge research thereby proposing a working model for regulation of caspase-4, -5 in pathogen elimination via cellular-trafficking.

1. Introduction

The response towards an invading pathogen in the human body is part of a sophisticated system in innate immunity which involves a multitude of pro-inflammatory steps as a first line of defense. The initial steps involve the ability to sense “danger” signals such as microbial or host stress molecules via an array of recognition receptors (e.g., Pattern recognition receptors (PRRs), Toll-like receptors (TLRs), Nucleotide oligomerization domain (NOD)-like receptors (NLRs)) [1]. One platform that the immune system utilizes to trigger a pro-inflammatory response is called the inflammasome, a multimeric protein complex which forms in the cytosol in response to pathogenic microbes or danger signals, and triggers the secretion of mature pro-inflammatory cytokines, interleukin-1β (IL-1β) and interleukin-18 (IL-18) ultimately leading to a form of cell death called pyroptosis [1,2,3,4].
Inflammasomes, as described in multiple reviews, are grouped into canonical and noncanonical pathways [1,2,3,5,6]. A functional canonical inflammasome complex is typically composed of a nucleotide-binding domain leucine-rich repeat (NLR) protein, an adaptor molecule apoptosis-associated speck-like protein containing a CARD (ASC) domain, and caspase-1 [7]. The upstream regulators and specific molecules which form the inflammasome complex however depend on the danger signal/microbial inducer(s) [1]. For example, the most fully characterized NLR, pyrin domain containing 3 (NLRP3) inflammasome can be activated by extracellular ATP (eATP) danger signaling via the P2X7 receptor, reactive oxygen species (ROS) and/or from exposure to whole pathogens (Figure 1). In contrast, the AIM2 inflammasome is specifically activated by sensing double-stranded DNA in the cytosol and the interleukin-1β-converting enzyme (ICE) protease-activating factor (IPAF) inflammasome is activated by Gram-negative bacteria (e.g., Salmonella typhimurium, Shigella flexneri, Legionella pneumophila, and Pseudomonas aeruginosa) which have type III or IV secretion systems [1]. There are multiple inflammasomes, thoroughly reviewed in recent literature [8,9], which are activated by different distinct mechanisms yet converge to the maturation and release of pro-inflammatory cytokines IL-1β [8,9].
Over the past couple of years, special attention has been given to the cysteine-aspartic specific protease, murine caspase-11 (human orthologs caspase-4, -5) as a factor which drives noncanonical inflammasome activation [6,10,11,12,13]. Caspase-11 is classified as an inflammasome caspase grouped with human caspase-1, -4, -5, -12 (murine caspase-1, -11, -12), which are produced as monomeric zymogens that are then activated by dimerization and cleavage [14]. Once cleaved, these caspases can function as critical mediators of innate immunity in response to pathogenic stimuli [12,14]. Caspase-11 has become of specific interest in cellular microbiology due to its specific response to Gram-negative bacterial infection and novel ability to become activated from direct binding of the caspase activation and recruitment domain (CARD) to cytosolic lipopolysaccharide (LPS) via the lipid A moiety [12,15,16]. Caspase-11 binds and is activated by LPS with structural specificity to LPS containing six acyl groups, however species with four acyl groups, although able to bind, has not been shown to activate caspase-11 [17].
Figure 1. The role of caspase-11 in noncanonical inflammasome activation and anti-bacterial autophagy. 1: Activation of the NLRP3 inflammasome via caspase-1 leading to caspase-1 activation and an increase in the secretion of IL-1β and IL-18 [8,10,12]. Caspase-11 can form heterocomplexes with caspase-1 promoting the activation of NLRP3 inflammasome in response to Gram-negative bacterial infection [12]; 2: Caspase-11 promotes the destruction of the replicative niche of intracellular pathogens by promoting phagolysosomal fusion of pathogen-containing phagosomes through actin mobilization [6].
Figure 1. The role of caspase-11 in noncanonical inflammasome activation and anti-bacterial autophagy. 1: Activation of the NLRP3 inflammasome via caspase-1 leading to caspase-1 activation and an increase in the secretion of IL-1β and IL-18 [8,10,12]. Caspase-11 can form heterocomplexes with caspase-1 promoting the activation of NLRP3 inflammasome in response to Gram-negative bacterial infection [12]; 2: Caspase-11 promotes the destruction of the replicative niche of intracellular pathogens by promoting phagolysosomal fusion of pathogen-containing phagosomes through actin mobilization [6].
Ijms 16 23337 g001
So far there are two cellular effects that have been described as result of caspase-11 activation. The first is the activation of the NLRP3 inflammasome leading to caspase-1 activation and an increase in the secretion of IL-1β and IL-18 [8,10,12]. Caspase-11 can form heterocomplexes with caspase-1 thereby inducing caspase-1-dependent pyroptosis in response to stress stimuli [12,18,19]. Second, Akhter et al. describes the ability of caspase-11 to destroy the replicative niche of intracellular pathogens by promoting fusion of the lysosome to pathogen-containing phagosomes [6]. This suggests a specific mechanism for caspase-11 in anti-bacterial autophagy independently of caspase-1 which may then lead to pyroptosis (Figure 1) [6,15,16]. The activation mechanisms and requirement of LPS binding for the promotion of phagolysosomal fusion by caspase-11 have not yet been fully studied.
Thus far, the focus of caspase-11 research has been solely on the ability of caspase-11 to induce noncanonical inflammasome activation, whereas its potential role in anti-bacterial autophagy has been otherwise ignored. Therefore, in this review, we examine murine caspase-11 and human orthologs caspase-4 and -5 as a potential regulator(s) of anti-bacterial autophagy by promoting phagolysosomal fusion in response to bacterial infection [6]. In addition, we discuss the potential implications of a danger signal, eATP, and ROS generation as novel inducers of human caspase-4 and -5 pathways during infection.

2. Inflammatory Murine Caspase-11

Caspase-11 was discovered based on its close similarity to caspase-1 and ability to induce pyroptosis [18]. The resting expression of caspase-11 is relatively low, with the exception of some epithelial cells [20,21], and is induced by detection of cytosolic LPS independently of the extracellular and vacuolar LPS receptor, Toll-like receptor 4 (TLR4) as repeatedly shown in vitro in macrophages, lymphocytes, hepatocytes, and epithelial cell studies [10,11,22,23,24] as well as in vivo [10,16,19]. The diversity of cell types in which caspase-11 functions is matched by the wide variety of pathogen infections it is able to protect the host from: Burkholderia pseudomallei, Burkholderia thailandensis, S. typhimurium, Candida albicans, S. flexneri, Enteropathogenic Escherichia coli and L. pneumophila [15,22,25,26,27,28].
Caspase-11 is transcribed from the same chromosomal locus as caspase-1 and localizes in the cytosol of the murine cell [18,19,22]. The expression and activation of caspase-11, in addition to direct binding with LPS, requires a priming signal by a pattern recognition receptor or damage-associated molecular pattern molecules (DAMPs) that induce transcriptional changes for inflammatory components [12,23,29]. Studies have shown evidence of IFN-β and IFN-γ in the activation of caspase-11 [29,30]. Moreover, the promoter region of caspase-11 contains several transcription factor binding sites including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and signal transducer and activation of transcription 1 (STAT1)-binding sites [29]. The priming adjuvant for caspase-11 activation is then followed by a triggering signal (e.g., recognition of cytosolic LPS) to initiate the proteolytic cleavage of caspase-11 and cascade of irreversible cellular events such as pyroptosis/inflammation [12,23,29].
Until recently, the precise way of pyroptosis induction by caspase-11 has remained an unknown. Two recent novel studies have opened a window to understanding the specific mode of caspase-11 pyroptosis initiation [31,32]. The protein, gasdermin D (GSDMD), was identified as key molecule in LPS-stimulated pyroptosis by two genetic screens as described in Shi et al. [31] and Kayagaki et al. [32]. Both studies presented reproducible results indicating the cleavage of GSDMD is required for pyroptosis induction. Caspase-1, -4, -5, and -11 are all shown to cleave GSDMD; however caspase-11 was unable to cleave GSDMD unless first activated by LPS treatment. Therefore, GSDMD is proposed as a direct substrate of caspase-11 needed for pyroptosis induction [31,32]. These findings are the first depiction of a detailed action of caspase-11 in pyroptosis stimulation. Similarly, caspase-11 may have other, yet unidentified, substrates required for caspase-11 mediated anti-bacterial autophagy.

3. Are Human Caspase-4 and -5 Functional Orthologs of Murine Caspase-11?

As the function of murine caspase-11 especially in the immune response to Gram-negative bacterial infections becomes increasingly important, establishing functional conservation in human caspase-4 and -5 is critical to understanding this pathway as it relates to human systems. Currently, literature deriving from separate original studies suggests that human caspase-4 and -5 are functional orthologs of caspase-11. However, to date, there is still no clear answer.
As previously described, the ability of murine caspase-11 directly bind and sense cytosolic LPS is novel and unique as compared to other well-characterized inflammatory caspases in the activation of noncanonical inflammasome and pyroptosis [10,33]. Moreover, activation of caspase-11 requires a priming and triggering signal which can be attributed to LPS, IFN-β, IFN-γ, NF-κB, and STAT1 molecules [29,30]. Although majority of the studies of noncanonical inflammasome activation have been investigated in primary murine macrophages (caspase-11), evidence exists to support inflammasome regulation by human caspase-4 and -5 [34,35]. Human caspase-4 and -5 also bind directly to LPS and contain the same binding sites for upstream regulators NF-κB, STAT1 and IFN-γ [10,12,29,36], strongly suggesting a similar regulatory mechanisms between both murine and human caspases. In addition, the ability of human caspase-4 and -5 to induce pyroptosis in response to cytosolic LPS has been demonstrated in vitro [17]. Shi et al. demonstrated in macrophages, keratinocytes (HaCaT), and certain epithelial cells (HeLa, HT-29) the ability of caspase-4 to bind to cytosolic LPS and induce pyroptosis. Most intriguingly, caspase-4 was also able to replace caspase-11 function in casp11 knockdown murine macrophages [17]. Similarly, Kajiwara et al. demonstrated the functional substitution capability of caspase-4 and -5 for caspase-11 in response to LPS when casp11 is deleted in vivo [34]. Growing studies continue to demonstrate conserved function between human caspase-4, -5 and murine caspase-11 as shown in Shi et al. and Kayagaki et al. which describe caspase-4, -5’s ability to cleave GSDMD, a cytoplasmic protein required for LPS-induced pyroptosis [31,32].
Caspase-4 and -5 are believed to have come from a gene duplication event [37] and although recent studies show conserved functions; there is also some slight divergence between caspase-4 and -5 which have been observed. Caspase-5 was initially proposed to be the human ortholog of caspase-11 because of its similar expression pattern and sequence homology [38] whereas caspase-4 was not as well studied in earlier years [39]. However, recent examination has suggested that caspase-4 and -5 may play a non-redundant role in different cell types. For example, Casson et al. demonstrated an ability of caspase-4 to activate the inflammasome and induce pyroptosis in macrophages in response to L. pneumophila, Yersinia pseudotuberculosis, and S. typhimurium infection [10]. Caspase-5, however, although its expression was upregulated, was not cleaved and activated by the above pathogen infections. Another example was presented in a study by Knodler et al. which showed that in gut epithelial cells, caspase-4 expression was most abundant [11]. Furthermore, the maturation of pro-inflammatory cytokine IL-18 as a result of noncanonical inflammasome activation was prevented by siRNA knockdown of caspase-4 thereby enhancing the number of S. typhimurium which survived in the gut epithelium. However, knockdown of caspase-1 or caspase-5 did not have the same effect on inflammasome activation, IL-18 secretion or bacterial survival [11]. Based on the abundance of caspase-4 in keratinocytes and other epithelial cell types, it is tempting to speculate that caspase-4 has key importance in mucosal innate defenses and possibly in facilitating rapid signaling for the promotion of adaptive immunity [11,20,35].
Despite both caspase-4 and -5 possessing the ability to bind LPS [33,34], caspase-5 expression is inducible by LPS similar to caspase-11; however caspase-4 is constitutively expressed in human epithelial cells and is reported to be only modestly induced upon infection [11,18,34]. In contrast, studies in human primary macrophages show caspase-4 and not caspase-5 to be inducible by LPS [10]. These differences in LPS-driven induction provide further evidence that caspase-4 and -5 function may be cell-type specific. It also suggests potential additional mode(s) of regulation when we discuss the role of caspase-11, -4, and -5 in anti-bacterial autophagy (phagolysosomal fusion) [6], Currently, it has not been examined whether LPS is required for this function or if caspase-4 and -5 ability to promote fusion can be controlled by another regulatory mechanism.
Taken together, the current literature suggests that human orthologs caspase-4 and -5 function similarly to murine caspase-11 in the activation of the noncanonical inflammasome and induction of pyroptosis in response to infection and LPS detection. However, differences revealed in the studies describe that caspase-4 and -5 may vary in expression and response depending on the cell type or pathogenic stimuli [10,11,17]. Moreover, caspase-4 may have specific functions in mucosal immunity that caspase-5 has not yet been shown to have. Currently, there is no study that demonstrates caspase-4 and -5 working in conjunction, which suggests a non-redundant role for them in promoting immune response to Gram-negative bacteria.

4. Murine Caspase-11 and Anti-Bacterial Autophagy Systems: A Conserved Role in Humans?

In innate immunity, LC3-associated phagocytosis (LAP) and autophagic clearance of invading bacteria are distinguished by the presence of a single or double-membrane vacuole formation [40]. Both LAP and autophagy pathways share similar upstream triggers (e.g., TLRs) and share some of the same machinery such as LC3, ATG5, and NADPH oxidase (NOX) which suggest that these two pathways may tightly collaborate in the host defense systems [41,42,43]. Moreover, some bacteria are able to escape the nascent phagosome by rupturing the membrane, which may result in the host response of forming the double-membrane autophagosome as a secondary clearance mechanism. In other instances, the phagosome membrane may undergo structural shifts thereby resulting in generation of reactive oxygen species (ROS) from NOX and thus more rapid clearance of the invading bacteria [44,45]. Regardless, the route, of bacterial killing, the final phagolysosomal fusion steps in both autophagy and LAP are similar (Figure 2) [44,46,47]. Therefore for the sake of importance, we will focus the remaining discussion on the described stages of autophagy and the relationship of caspase-11; however we do not negate that proposed mechanisms could also be attributed to LAP.
Autophagy generally functions to eliminate microorganisms, control pro-inflammatory signaling, regulate adaptive immunity and mediate secretion of immune regulators [41,46]. Autophagy has five major steps regulated by a variety of autophagy proteins: (1) induction; (2) vesicle nucleation; (3) elongation; (4) docking and fusion, and finally; and (5) degradation and recycling [44,46,48] (Figure 2). At the initial step, a phagophore is generated by cytoskeletal rearrangements by the membrane which surrounds an infectious agent. This involves ATG proteins 5, 12 and 16L1 undergoing a series of conjugation and cleavage steps to form a double-membrane organelle called an autophagosomes [44,46,48]. During maturation, the autophagosome directly fuses with the lysosome to form the autolysosome which degrades autophagosomal contents together with the inner autophagosomal membrane [41,46,49]. Fusion with the lysosome (step 4) is a late stage maturation event in anti-bacterial autophagy that is strictly regulated and requires the involvement of Rab-family GTPases which mediate the changes between phagosomes stages, tethering proteins such as soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNAREs) such as Syntaxin 17, pH changes in the intracellular compartment of the phagosomes, and lysosomal enzyme synthesis in order to degrade the intracellular cargo [41,44,46,49,50,51].
Figure 2. Progression of LC3-associated phagocytosis (LAP) and anti-bacterial autophagy in response to infection. Left: LAP begins by phagocytosis of the bacteria into the cell. Reactive oxygen species (ROS) generated by NADPH oxidase (NOX) as a result of extracellular ATP/P2X7 signaling can disturb the integrity of the phagosome resulting in either bacterial escape into the cytosol or recruitment of LC3 to the phagosome isolation membrane by ATG5 [41,42,43]. Attachment of LC3 to the membrane promotes rapid fusion with the lysosome resulting in microbial killing [44,46]; Right: Bacteria that escape the nascent phagosome can be targeted for autophagic clearance. Autophagy has five major steps: (1) induction; (2) vesicle nucleation; (3) elongation; (4) docking and fusion; and (5) degradation and recycling [44,46,48]. Initially, a phagophore surrounds the bacteria. This involves ATG proteins 5, 12 and 16L1 which initiate a cascade of conjugation steps to form a closed double-membrane organelle called an autophagosome [44,46,48]. The phagosome matures similar to LAP where it directly fuses with the lysosome to and degrades the autophagosomal contents together with the inner autophagosomal membrane [46]. The attachment of Syntaxin 17 allows for fusion to occur [49] while Rab GTPases are important determinants for each stage of maturation [44].
Figure 2. Progression of LC3-associated phagocytosis (LAP) and anti-bacterial autophagy in response to infection. Left: LAP begins by phagocytosis of the bacteria into the cell. Reactive oxygen species (ROS) generated by NADPH oxidase (NOX) as a result of extracellular ATP/P2X7 signaling can disturb the integrity of the phagosome resulting in either bacterial escape into the cytosol or recruitment of LC3 to the phagosome isolation membrane by ATG5 [41,42,43]. Attachment of LC3 to the membrane promotes rapid fusion with the lysosome resulting in microbial killing [44,46]; Right: Bacteria that escape the nascent phagosome can be targeted for autophagic clearance. Autophagy has five major steps: (1) induction; (2) vesicle nucleation; (3) elongation; (4) docking and fusion; and (5) degradation and recycling [44,46,48]. Initially, a phagophore surrounds the bacteria. This involves ATG proteins 5, 12 and 16L1 which initiate a cascade of conjugation steps to form a closed double-membrane organelle called an autophagosome [44,46,48]. The phagosome matures similar to LAP where it directly fuses with the lysosome to and degrades the autophagosomal contents together with the inner autophagosomal membrane [46]. The attachment of Syntaxin 17 allows for fusion to occur [49] while Rab GTPases are important determinants for each stage of maturation [44].
Ijms 16 23337 g002
Bacteria which are contained in phagosomes are detected by caspase-11 mainly through interferon inducible guanylate binding proteins (GBDs) which can alter the phagosomal membrane integrity thus allowing for LPS to release into the cytosol [52,53]. Bacteria may also escape the phagosome and reside in the cytosol thereby exposing caspase-11 to LPS resulting in the activation of noncanonical inflammasome [24,54]. However, many bacteria have developed mechanisms to counteract different steps in the anti-bacterial autophagic pathway in order to acquire replicative niches, promote persistence, and minimize “danger” signals from the host [51,55,56]. For example, pathogens like Coxiella burnetti, L. pneumophila, Staphylococcus aureus, Mycobacterium tuberculosis and Brucella abortus are able to counteract autophagic pathways for their intracellular survival by retarding the phagosome maturation process, escaping the phagosome, forming separate non-autophagic ER-rich vacuoles, and modulating host GTPase activation thereby affecting cytoskeletal rearrangement associated with anti-bacterial autophagy [51,56,57]. Other pathogens have developed ways to utilize the autophagic system [55] and create a replicative niche within autophagosomes like successful oral pathogen, Porphyromonas gingivalis [58,59]. P. gingivalis is a Gram-negative anaerobe and effective colonizer of oral mucosa that can affluently persist in oral epi-mucosal cells and downregulate the epithelial immune response [58,60,61,62,63,64,65]. P. gingivalis survives predominantly inside ER-rich autophagosomes in primary gingival epithelial cells as well as endothelial cells either by preventing the fusion of autophagolysosomes or completely inhibiting normal autophagic flow [51,58,66,67]. In other instances, autophagy is able to effectively eliminate the invading pathogen as is the case with Mycobacterium smegmatis, S. typhimurium, and B. pseudomallei [51,68]. This describes a dynamic interplay between pathogen survival and autophagy machinery where autophagy targets bacteria for degradation and bacteria use that same host machinery to create an intracellular niche for survival [51,55,56].
Murine caspase-11 and human functional orthologs caspase-4 and -5 have been suggested to play an important role in the autophagic pathway having an independent function in controlling the fusion of pathogen-containing phagosomes with lysosomes via actin polymerization leading to restriction of L. pneumophila growth in macrophages [6]. Past this study there has not been much investigation into the role of caspase-11, -4, or -5 in bacterial killing specifically by phagolysomal fusion. However, a study on caspase-4 function during S. typhimurium infection in human intestinal epithelial cells revealed that casp4 depletion enhanced cytosolic replication of S. typhimurium, but did not affect vacuolar replication [11]. This novel observation demonstrates the high level involvement of caspase-4 in restricting bacterial growth (S. typhimurium) and also suggests the ability of caspase-4 to activate host bacterial clearance mechanisms in response to cytosolic bacterial stimuli. There is some overlap between the upstream regulators of phagolysosomal fusion and regulators of caspase-4 activation which may also suggest a critical role for caspase-4 in promoting fusion of pathogen-containing phagosomes. For example, in macrophages, NF-κB controls phagolysosome fusion in the presence of M. tuberculosis infection [68]. Similarly, both human caspase-4, and -5 as well as murine caspase-11, expression and activation has been shown to be, in part, regulated by NF-κB [10,12,29,36]. Therefore, human caspase-4 and -5 may have an essential function in regulating phagolysosomal fusion, however additional studies are required to completely answer this question.
Furthermore, as other bacteria described before have the ability to counteract autophagic pathways, there is also evidence of the ability to inhibit caspase-4. S. flexneri possesses a caspase-inhibitor, bacterial effector OspC3, which blocks caspase-4 activation by binding in the catalytic pocket of caspase-4 [27] and Francisella novicida encodes an LPS that is not readily detectable in murine macrophages [10]. Another example is the oral pathogen that survives in ER-rich autophagosomes P. gingivalis, [51,58] which has heterogeneous expression of different lipid a moieties [69]. Using lipid A phosphatases to alter the lipid A composition of its expressed LPS, P. gingivalis may therefore manipulate the immune response by expressing an underacylated LPS [69,70,71] which can bind, but not activate caspase-11 (human caspase-4,-5) [70,72].
Although murine caspase-11 and human orthologs caspase-4, -5 have been poorly explored, it is our belief that the evidence described that suggests an importance for murine caspase-11 and human caspase-4 and -5 in the promotion of phagolysosomal fusion and bacterial killing. This function has not yet been investigated for caspase-5; however, it would be of great interest and value to examine this potentially novel function further. Considering that all other studies examining caspase-11, -4 and -5 before and after the 2012 Akhter et al. study [6] have focused on noncanonical inflammasome activation via detection of cytosolic LPS, we would like to suggest that there may be unexplored regulators of caspase-11 in addition to LPS that may promote specifically caspase function in mediating phagolysosomal fusion. This may provide additional explanation for the utilization of the caspase-11 pathway by other opportunistic microbes such as C. albicans that do not contain LPS [26].

5. Are eATP and ROS Important in Caspase-4/11-Mediated Bacterial Defense?

Currently the model for caspase-11 activation is that of a two-hit mechanism of a priming step and subsequent LPS recognition trigger of proteolytic cleavage [12]. Exploring the molecules involved in priming would give more insight into the regulatory mechanisms of the proposed anti-bacterial autophagy function (phagolysomal fusion) of caspase-11 specific for clearance of Gram-negative bacteria. Summarized below are potential connections made between eATP, ROS and anti-bacterial autophagy (Figure 3). The connections made are intended to incite interest into examining these pathways in response to Gram-negative infections and chronic infections across cell types, with the aim of better understanding the innate immune responses for therapeutic gains and insight in the field.
Pathogen infection usually results in host changes in ion fluxes, membrane damage, and ROS generation [28]. Over time some pathogens have developed the ability to circumvent the innate host defense systems such as autophagy, inflammasome, and ROS, through mimicry of human cell components, inhibition of pro-apoptotic and inflammatory pathways, or the formation of protective replicative niches within the host cell [51,56]. Many of these immune pathways have been studied in a variety of cell types because of the diversity of the pathogens able to invade cells at different sites in the body.
ROS is critically important in regulating antimicrobial defenses in the host cell and has a biocidal function at elevated levels [46,48,73]. Although there are multiple regulators of ROS, danger signal eATP is of specific interest in this review because of its significance in regulating immune responses to bacterial infections as well as its relationship to inflammasome activation and anti-bacterial autophagy [74,75,76]. eATP is an endogenous pro-inflammatory “danger” signal which is released from the host cell in response to cellular stress, injury, or infection [77,78]. Innate immune cells as well as epithelial cells express P2X receptors, in particular P2X7 and P2X4, which when bound to ATP, open calcium and potassium permeable ion channels that initiate a cascade of pro-inflammatory signaling modulators including ROS [75,79,80,81]. ATP activation of the P2X7 receptor further induces caspase-1-dependent inflammasome activation and subsequent IL-1β release [60,75,82,83]. Interestingly, the oral pathogen P. gingivalis is able to modulate eATP/P2X7 pathways including IL-1β production/release from primary epithelial cells by secretion of an effector, nucleoside-diphosphate-kinase (Ndk), to catalytically deplete eATP thereby modulating the ROS/oxidative stress and inhibit host cell death [60,62,63,65,84]. P. gingivalis modulation of ROS may promote its survival in ER-rich autophagosomes as the production of ROS coincides with initiation of autophagy in the epithelial cells [51,58,63,66,67]. Further evidence for the newly developing cross-talk between eATP, ROS, and anti-bacterial autophagy is described below.
Not surprisingly, in addition to canonical and noncanonical inflammasome, eATP-induced ROS production has been implicated in autophagy as well [28]. A study in 2008 in human macrophages showed that intracellular Mycobacterium bovis infections were cleared by eATP/P2X7-mediated phagolysosomal fusion [85]. Inhibition of the P2X7 receptor successfully blocked phagolysosomal fusion of M. bovis-containing phagosomes [85]. Another study in 2009 using microglial cells demonstrated the release of autolysosomes into the extracellular space as a pathogen clearance mechanism in response to the activation of the P2X7 receptor by eATP [86]. There are also regulators or products of caspase-11 activation which overlap with pro-autophagy machinery (e.g., IFN-γ, NLRPs, IL-1β) suggesting possible cross-talk between murine caspase-11 (human caspase-4 and -5) and eATP signaling [10,29,36,46].
A study in 2009 linked for the first time eATP to the activation of the NOX2 isoform in murine endotoxin-primed macrophages [79]. This however is poorly characterized and may be tissue-specific according to Meissner 2008 who showed murine peritoneal macrophages, which have distinct differences to adherent macrophages [87], did not have NOX2-specific ROS generation in response to eATP [88]. eATP has also been shown to have effect on the generation of ROS from other NOXs such as DUOX1 which generates peroxide (H2O2) in response to TLR ligands and produces pro-inflammatory cytokines [77]. The specific mechanisms, however, are also not currently known [77]. Therefore the specific isoform of NOX promoted by eATP signaling may be cell-type specific, however the generated downstream ROS has similar effects on pathogen killing [46]. Regardless, NOX-generated ROS has specific functions in regulating autophagy by targeting bacteria-containing phagosomes as described in Huang et al. [89]. This study demonstrated the importance of NOX2-generated ROS in the phagolysosome degradation pathway by recruiting critical autophagy proteins to the targeted S. typhimurium-containing phagosomes [48,89,90]. However, the specific mechanisms of this were not described. If we consider the independent function of caspase-11 in phagolysosomal fusion as described earlier [6] this would be an interesting path to explore in the activation of caspase-4 in humans. Another study identified an autophagy regulatory protein, RUBICON (run domain beclin 1-interacting and cysteine-rich-containing protein) that connects autophagy to NOX by positively regulating NOX-mediated ROS generation during microbial infection and promoting both phagocytosis and autophagy [47,91]. Therefore, studies have not yet concentrated in connecting eATP-induced ROS, NOX, and anti-bacterial autophagy pathways, however there is a myriad of strong implications of their importance in response to bacterial infection and potentially in regulating murine caspase-11 (human caspase-4 and -5) in phagolysosomal fusion.
Figure 3. Proposed mechanism of caspase-4 activation in promotion of phagolysosomal fusion during pathogen infection. Model: Extracellular ATP (eATP) is an endogenous pro-inflammatory “danger” signal which is released from the host cell in response to stressed, injured, or infected cells [77,78]. eATP binds and activates the P2X7 receptor which results in calcium influx into the cell and potassium efflux [75,79]. Activation of this receptor promotes the formation of an active NADPH oxidase (NOX) on the plasma membrane/phagosome membrane [28,79,89]. The NOX-mediated reactive oxygen species (ROS) promotes the activation of caspase-4 which facilitates phagolysosomal fusion resulting in bacterial killing [89].
Figure 3. Proposed mechanism of caspase-4 activation in promotion of phagolysosomal fusion during pathogen infection. Model: Extracellular ATP (eATP) is an endogenous pro-inflammatory “danger” signal which is released from the host cell in response to stressed, injured, or infected cells [77,78]. eATP binds and activates the P2X7 receptor which results in calcium influx into the cell and potassium efflux [75,79]. Activation of this receptor promotes the formation of an active NADPH oxidase (NOX) on the plasma membrane/phagosome membrane [28,79,89]. The NOX-mediated reactive oxygen species (ROS) promotes the activation of caspase-4 which facilitates phagolysosomal fusion resulting in bacterial killing [89].
Ijms 16 23337 g003

6. Conclusions

Holistic review of the current literature strongly points to potential key connections between eATP, NOX-mediated ROS-generation and anti-bacterial autophagy (e.g., phagolysosomal fusion). The role of caspase-11 and human functional orthologs caspase-4 and -5 in activation of noncanonical inflammasome has been well described [12,23] and new information is continually being disseminated on this topic to the scientific community. However, the role of these special enzymes and immune regulators in the promotion of pathogen-containing phagosome fusion has been greatly over looked and key questions in the field remain to be answered. First, the role of human caspase-4 and -5 in phagolysosomal fusion has not been explored mechanistically beyond actin polymerization nor has it been investigated in other cell types beyond macrophages. This is a limitation in that bacteria with the capability to survive by circumventing autophagy machinery have been shown to infect a variety of hematopoietic cells as well as epithelial cell types as is this case with chronic opportunistic pathogen infections at mucosal surfaces [27,51,55,56,57,58,67]. Moreover, studies have also indicated that there may be deviating roles and expression for caspase-4 and -5 depending on the cell type and the microbial inducer [10,11]. Notably, the studies point to a specific importance for caspase-4 in mucosal immunity since caspase-4 expression level and ability to be activated in response to infection highly differs compared with caspase-5 [11,35]. Accordingly, caspase-4 may provide valuable insight into the rapid sensing and clearance of bacteria at mucosal tissues. Second, eATP regulation of NOX-generated ROS appears to have key significance in autophagy based on data suggesting recruitment of autophagy machinery to pathogen-containing phagosomes and regulation by identified autophagy proteins such as RUBICON [45,47,48,89,91]. The link between these upstream immune regulators is still largely unexplored territory. Examination of the importance of these pathways in the activation of novel murine caspase-11 (human caspase-4, -5) function in autophagic clearance of bacteria may reveal interesting mechanistic insights, predispositions and potential therapeutic strategies for Gram-negative infections in humans. As we have eluded before, there may be alternate regulation mechanisms of caspase-11, -4, and -5 in addition to LPS binding. The ability of non-bacterial pathogens such as C. albicans [26] to activate caspase-11 as well as the different cell-type expression levels of caspase-4 and -5 upon stimulation support this possibility [10,11,17,18,34]. Furthermore, it has not been investigated if LPS or LPS alone is necessary for the potential role of caspase-4, -5 in promoting phagolysosomal fusion in anti-bacterial autophagy [6]. It may be of great interest to investigate other activation mechanisms of these inflammatory caspases to facilitate bacterial killing in host cells. In particular, bacterial pathogens with the potential ability to avoid bacterial clearance by phagolysosomal fusion or to inhibit caspase-4 such as P. gingivalis, M. tuberculosis, S. flexneri and F. novicida, would be prime candidates for future studies [10,27,51,70,71]. Hence, exploration into human caspase-4 and -5 function and regulatory mechanisms will provide critically novel insight into the regulation of human innate immune responses to pathogen infection at epi-mucosal sites and in immune cells. The information gained may provide novel treatment targets for Gram-negative bacterial infections and other pathogens that are able to direct host machinery promoting pathogen survival and persistence.

Acknowledgments

We would like to acknowledge the support of the NIDCR grants RO1DE016593, T90DE021990. Additionally, the authors would like to extend special thanks to Kalina R. Atanasova for her assistance in the preparation and design of the schematic diagrams.

Author Contributions

JoAnn Simone Roberts drafted the manuscript and worked in conjunction with Ӧzlem Yilmaz to produce the final version of the manuscript. All authors discussed and commented on the manuscript prior to submission.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schroder, K.; Tschopp, J. The inflammasomes. Cell 2010, 140, 821–832. [Google Scholar] [CrossRef] [PubMed]
  2. Yilmaz, O.; Lee, K.L. The inflammasome and danger molecule signaling: At the crossroads of inflammation and pathogen persistence in the oral cavity. Periodontology 2000 2015, 69, 83–95. [Google Scholar] [CrossRef] [PubMed]
  3. Latz, E.; Xiao, T.S.; Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013, 13, 397–411. [Google Scholar] [CrossRef] [PubMed]
  4. Martinon, F.; Burns, K.; Tschopp, J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proil-beta. Mol. Cell 2002, 10, 417–426. [Google Scholar] [CrossRef]
  5. Said-Sadier, N.; Ojcius, D.M. Alarmins, inflammasomes and immunity. Biomed. J. 2012, 35, 437–449. [Google Scholar] [PubMed]
  6. Akhter, A.; Caution, K.; Abu Khweek, A.; Tazi, M.; Abdulrahman, B.A.; Abdelaziz, D.H.A.; Voss, O.H.; Doseff, A.I.; Hassan, H.; Azad, A.K.; et al. Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity 2012, 37, 35–47. [Google Scholar] [CrossRef] [PubMed]
  7. De Veerdonk, F.L.V.; Netea, M.G.; Dinarello, C.A.; Joosten, L.A.B. Inflammasome activation and il-1 beta and il-18 processing during infection. Trends Immunol. 2011, 32, 110–116. [Google Scholar] [CrossRef] [PubMed]
  8. Eldridge, M.J.G.; Shenoy, A.R. Antimicrobial inflammasomes: Unified signalling against diverse bacterial pathogens. Curr. Opin. Microbiol. 2015, 23, 32–41. [Google Scholar] [CrossRef] [PubMed]
  9. Creagh, E.M. Caspase crosstallk: Integration of apoptotic and innate immune signalliing pathways. Trends Immunol. 2014, 35, 631–640. [Google Scholar] [CrossRef] [PubMed]
  10. Casson, C.N.; Yu, J.; Reyes, V.M.; Taschuk, F.O.; Yadav, A.; Copenhaver, A.M.; Nguyen, H.T.; Collman, R.G.; Shin, S. Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens. Proc. Natl. Acad. Sci. USA 2015, 112, 6688–6693. [Google Scholar] [CrossRef] [PubMed]
  11. Knodler, L.A.; Crowley, S.M.; Sham, H.P.; Yang, H.J.; Wrande, M.; Ma, C.X.; Ernst, R.K.; Steele-Mortimer, O.; Celli, J.; Vallance, B.A. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 2014, 16, 249–256. [Google Scholar] [CrossRef] [PubMed]
  12. Stowe, I.; Lee, B.; Kayagaki, N. Caspase-11: Arming the guards against bacterial infection. Immunol. Rev. 2015, 265, 75–84. [Google Scholar] [CrossRef] [PubMed]
  13. Vigano, E.; Mortellaro, A. Caspase-11: The driving factor for noncanonical inflammasomes. Eur. J. Immunol. 2013, 43, 2240–2245. [Google Scholar] [CrossRef] [PubMed]
  14. McIlwain, D.R.; Berger, T.; Mak, T.W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 2013, 5. [Google Scholar] [CrossRef]
  15. Case, C.L.; Kohler, L.J.; Lima, J.B.; Strowig, T.; de Zoete, M.R.; Flavell, R.A.; Zamboni, D.S.; Roy, C.R. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to legionella pneumophila. Proc. Natl. Acad. Sci. USA 2013, 110, 1851–1856. [Google Scholar] [CrossRef]
  16. Kayagaki, N.; Warming, S.; Lamkanfi, M.; Vande Walle, L.; Louie, S.; Dong, J.; Newton, K.; Qu, Y.; Liu, J.F.; Heldens, S.; et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479, U117–U146. [Google Scholar] [CrossRef] [PubMed]
  17. Shi, J.J.; Zhao, Y.; Wang, Y.P.; Gao, W.Q.; Ding, J.J.; Li, P.; Hu, L.Y.; Shao, F. Inflammatory caspases are innate immune receptors for intracellular lps. Nature 2014, 514, 187–192. [Google Scholar] [CrossRef] [PubMed]
  18. Wang, S.Y.; Miura, M.; Jung, Y.K.; Zhu, H.; Gagliardini, V.; Shi, L.F.; Greenberg, A.H.; Yuan, J.Y. Identification and characterization of ich-3, a member of the interleukin-1 beta converting enzyme (ice)/ced-3 family and an upstream regulator of ice. J. Biol. Chem. 1996, 271, 20580–20587. [Google Scholar] [CrossRef]
  19. Wang, S.Y.; Miura, M.; Jung, Y.K.; Zhu, H.; Li, E.; Yuan, J.Y. Murine caspase-11, an ice-interacting protease, is essential for the activation of ice. Cell 1998, 92, 501–509. [Google Scholar] [CrossRef]
  20. Demon, D.; Kuchmiy, A.; Fossoul, A.; Zhu, Q.; Kanneganti, T.D.; Lamkanfi, M. Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal. Immunol. 2014, 7, 1480–1491. [Google Scholar] [CrossRef] [PubMed]
  21. Kang, S.J.; Popat, R.; Bragdon, C.; O’Donnell, K.; Phelan, S.; Yuan, J.Y.; Sonis, S.T. Caspase-11 is not necessary for chemotherapy-induced intestinal mucositis. DNA Cell Biol. 2004, 23, 490–495. [Google Scholar] [CrossRef] [PubMed]
  22. Aachoui, Y.; Leaf, I.A.; Hagar, J.A.; Fontana, M.F.; Campos, C.G.; Zak, D.E.; Tan, M.H.; Cotter, P.A.; Vance, R.E.; Aderem, A.; et al. Caspase-11 protects against bacteria that escape the vacuole. Science 2013, 339, 975–978. [Google Scholar] [CrossRef] [PubMed]
  23. Broz, P.; Monack, D.M. Noncanonical inflammasomes: Caspase-11 activation and effector mechanisms. PLoS Pathog. 2013, 9. [Google Scholar] [CrossRef] [PubMed]
  24. Hagar, J.A.; Powell, D.A.; Aachoui, Y.; Ernst, R.K.; Miao, E.A. Cytoplasmic lps activates caspase-11: Implications in tlr4-independent endotoxic shock. Science 2013, 341, 1250–1253. [Google Scholar] [CrossRef] [PubMed]
  25. Broz, P.; Ruby, T.; Belhocine, K.; Bouley, D.M.; Kayagaki, N.; Dixit, V.M.; Monack, D.M. Caspase-11 increases susceptibility to salmonella infection in the absence of caspase-1. Nature 2012, 490, 288–291. [Google Scholar] [CrossRef]
  26. Gabrielli, E.; Pericolini, E.; Luciano, E.; Sabbatini, S.; Roselletti, E.; Perito, S.; Kasper, L.; Hube, B.; Vecchiarelli, A. Induction of caspase-11 by aspartyl proteinases of candida albicans and implication in promoting inflammatory response. Infect. Immun. 2015, 83, 1940–1948. [Google Scholar] [CrossRef] [PubMed]
  27. Kobayashi, T.; Ogawa, M.; Sanada, T.; Mimuro, H.; Kim, M.; Ashida, H.; Akakura, R.; Yoshida, M.; Kawalec, M.; Reichhart, J.M.; et al. The shigella ospc3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 2013, 13, 570–583. [Google Scholar] [CrossRef] [PubMed]
  28. Lupfer, C.R.; Anand, P.K.; Liu, Z.P.; Stokes, K.L.; Vogel, P.; Lamkanfi, M.; Kanneganti, T.D. Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical nlrp3 inflammasome during enteric pathogen infection. PLoS Pathog. 2014, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Schauvliege, R.; Vanrobaeys, J.; Schotte, P.; Beyaert, R. Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa b and signal transducer and activator of transcription (stat) 1. J. Biol. Chem. 2002, 277, 41624–41630. [Google Scholar] [CrossRef] [PubMed]
  30. Rathinam, V.A.K.; Vanaja, S.K.; Fitzgerald, K.A. Regulation of inflammasome signaling. Nat. Immunol. 2012, 13, 333–342. [Google Scholar] [CrossRef] [PubMed]
  31. Shi, J.; Zhao, Y.; Wang, K.; Shi, X.; Wang, Y.; Huang, H.; Zhuang, Y.; Cai, T.; Wang, F.; Shao, F. Cleavage of gsdmd by inflammatory caspases determines pyroptotic cell death. Nature 2015. [Google Scholar] [CrossRef] [PubMed]
  32. Kayagaki, N.; Stowe, I.B.; Lee, B.L.; O′Rourke, K.; Anderson, K.; Warming, S.; Cuellar, T.; Haley, B.; Roose-Girma, M.; Phung, Q.T.; et al. Caspase-11 cleaves gasdermin d for non-canonical inflammasome signaling. Nature 2015. [Google Scholar] [CrossRef] [PubMed]
  33. Yang, J.; Zhao, Y.; Shao, F. Non-canonical activation of inflammatory caspases by cytosolic lps in innate immunity. Curr. Opin. Immunol. 2015, 32, 78–83. [Google Scholar] [CrossRef]
  34. Kajiwara, Y.; Schiff, T.; Voloudakis, G.; Sosa, M.A.G.; Elder, G.; Bozdagi, O.; Buxbaum, J.D. A critical role for human caspase-4 in endotoxin sensitivity. J. Immunol. 2014, 193, 335–343. [Google Scholar] [CrossRef] [PubMed]
  35. Sollberger, G.; Strittmatter, G.E.; Kistowska, M.; French, L.E.; Beer, H.D. Caspase-4 is required for activation of inflammasomes. J. Immunol. 2012, 188, 1992–2000. [Google Scholar] [CrossRef] [PubMed]
  36. Yang, H.J.; Wang, M.; Wang, L.; Cheng, B.F.; Lin, X.Y.; Feng, Z.W. Nf-kappa b regulates caspase-4 expression and sensitizes neuroblastoma cells to fas-induced apoptosis. PLoS ONE 2015, 10. [Google Scholar] [CrossRef]
  37. Martinon, F.; Tschopp, J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ. 2007, 14, 10–22. [Google Scholar] [CrossRef] [PubMed]
  38. Lin, X.Y.; Choi, M.S.; Porter, A.G. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the casp5 gene by lipopolysaccharide and interferon-gamma. J. Biol. Chem. 2000, 275, 39920–39926. [Google Scholar] [CrossRef] [PubMed]
  39. Martinon, F.; Tschopp, J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004, 117, 561–574. [Google Scholar] [CrossRef] [PubMed]
  40. Cemma, M.; Brumell, J.H. Interactions of pathogenic bacteria with autophagy systems. Curr. Biol. 2012, 22, R540–R545. [Google Scholar] [CrossRef] [PubMed]
  41. Mehta, P.; Henault, J.; Kolbeck, R.; Sanjuan, M.A. Noncanonical autophagy: One small step for lc3, one giant leap for immunity. Curr. Opin. Immunol. 2014, 26, 69–75. [Google Scholar] [CrossRef] [PubMed]
  42. Sanjuan, M.A.; Dillon, C.P.; Tait, S.W.; Moshiach, S.; Dorsey, F.; Connell, S.; Komatsu, M.; Tanaka, K.; Cleveland, J.L.; Withoff, S.; et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450, 1253–1257. [Google Scholar] [CrossRef] [PubMed]
  43. Delgado, M.A.; Elmaoued, R.A.; Davis, A.S.; Kyei, G.; Deretic, V. Toll-like receptors control autophagy. EMBO J. 2008, 27, 1110–1121. [Google Scholar] [CrossRef] [PubMed]
  44. Fairn, G.D.; Grinstein, S. How nascent phagosomes mature to become phagolysosomes. Trends Immunol. 2012, 33, 397–405. [Google Scholar] [CrossRef] [PubMed]
  45. Huang, J.; Brumell, J.H. Nadph oxidases contribute to autophagy regulation. Autophagy 2009, 5, 887–889. [Google Scholar] [CrossRef] [PubMed]
  46. Deretic, V.; Saitoh, T.; Akira, S. Autophagy in infection, inflammation and immunity. Nat. Rev. Immunol. 2013, 13, 722–737. [Google Scholar] [CrossRef] [PubMed]
  47. Boyle, K.B.; Randow, F. Rubicon swaps autophagy for lap. Nat. Cell Biol. 2015, 17, 843–845. [Google Scholar] [CrossRef] [PubMed]
  48. Wen, X.; Wu, J.M.; Wang, F.T.; Liu, B.; Huang, C.H.; Wei, Y.Q. Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radic. Biol. Med. 2013, 65, 402–410. [Google Scholar] [CrossRef] [PubMed]
  49. Itakura, E.; Kishi-Itakura, C.; Mizushima, N. The hairpin-type tail-anchored snare syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012, 151, 1256–1269. [Google Scholar] [CrossRef] [PubMed]
  50. Nordenfelt, P.; Tapper, H. Phagosome dynamics during phagocytosis by neutrophils. J. Leukoc. Biol. 2011, 90, 271–284. [Google Scholar] [CrossRef] [PubMed]
  51. Campoy, E.; Colombo, M.I. Autophagy in intracellular bacterial infection. BBA-Mol. Cell Res. 2009, 1793, 1465–1477. [Google Scholar] [CrossRef] [PubMed]
  52. Meunier, E.; Dick, M.S.; Dreier, R.F.; Schurmann, N.; Broz, D.K.; Warming, S.; Roose-Girma, M.; Bumann, D.; Kayagaki, N.; Takeda, K.; et al. Caspase-11 activation requires lysis of pathogen-containing vacuoles by ifn-induced gtpases. Nature 2014, 509, 366–370. [Google Scholar] [CrossRef] [PubMed]
  53. Pilla, D.M.; Hagar, J.A.; Haldar, A.K.; Mason, A.K.; Degrandi, D.; Pfeffer, K.; Ernst, R.K.; Yamamoto, M.; Miao, E.A.; Coers, J. Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic lps. Proc. Natl. Acad. Sci. USA 2014, 111, 6046–6051. [Google Scholar] [CrossRef] [PubMed]
  54. Hagar, J.A.; Miao, E.A. Detection of cytosolic bacteria by inflammatory caspases. Curr. Opin. Microbiol. 2014, 17, 61–66. [Google Scholar] [CrossRef] [PubMed]
  55. Huang, J.; Brumell, J.H. Bacteria-autophagy interplay: A battle for survival. Nat. Rev. Microbiol. 2014, 12, 101–114. [Google Scholar] [CrossRef] [PubMed]
  56. Alix, E.; Mukherjee, S.; Roy, C.R. Host-pathogen interactions subversion of membrane transport pathways by vacuolar pathogens. J. Cell Biol. 2011, 195, 943–952. [Google Scholar] [CrossRef] [PubMed]
  57. Cambier, C.J.; Falkow, S.; Ramakrishnan, L. Host evasion and exploitation schemes of mycobacterium tuberculosis. Cell 2014, 159, 1497–1509. [Google Scholar] [CrossRef] [PubMed]
  58. Choi, C.H.; Lee, K.; Atanasova, K.R.; Spooner, R.; Yilmaz, O. P. Gingivalis traffics into er-rich-autophagosomes for successful survival in gingival-epithelial-cells. In Proceedings of the International Association for Dental Research, Seattle, WA, USA, 20–23 March 2013.
  59. Yilmaz, O. The chronicles of porphyromonas gingivalis: The microbium, the human oral epithelium and their interplay. Microbiology 2008, 154, 2897–2903. [Google Scholar] [CrossRef] [PubMed]
  60. Yilmaz, O.; Sater, A.A.; Yao, L.Y.; Koutouzis, T.; Pettengill, M.; Ojcius, D.M. Atp-dependent activation of an inflammasome in primary gingival epithelial cells infected by porphyromonas gingivalis. Cell. Microbiol. 2010, 12, 188–198. [Google Scholar] [CrossRef]
  61. Yilmaz, O.; Verbeke, P.; Lamont, R.J.; Ojcius, D.M. Intercellular spreading of porphyromonas gingivalis infection in primary gingival epithelial cells. Infect. Immun. 2006, 74, 703–710. [Google Scholar] [CrossRef] [PubMed]
  62. Yilmaz, O.; Yao, L.; Maeda, K.; Rose, T.M.; Lewis, E.L.; Duman, M.; Lamont, R.J.; Ojcius, D.M. Atp scavenging by the intracellular pathogen porphyromonas gingivalis inhibits p2x7-mediated host-cell apoptosis. Cell. Microbiol. 2008, 10, 863–875. [Google Scholar] [CrossRef] [PubMed]
  63. Choi, C.H.; Spooner, R.; DeGuzman, J.; Koutouzis, T.; Ojcius, D.M.; Yilmaz, O. Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits atp-induced reactive-oxygen-species via p2x7 receptor/nadph-oxidase signalling and contributes to persistence. Cell Microbiol. 2013, 15, 961–976. [Google Scholar] [CrossRef] [PubMed]
  64. Atanasova, K.R.; Yilmaz, O. Prelude to oral microbes and chronic diseases: Past, present and future. Microbes Infect. 2015, 17, 473–483. [Google Scholar] [CrossRef] [PubMed]
  65. Johnson, L.; Atanasova, K.R.; Bui, P.Q.; Lee, J.; Hung, S.C.; Yilmaz, O.; Ojcius, D.M. Porphyromonas gingivalis attenuates atp-mediated inflammasome activation and hmgb1 release through expression of a nucleoside-diphosphate kinase. Microbes Infect. 2015, 17, 369–377. [Google Scholar] [CrossRef] [PubMed]
  66. Choi, C.H.; DeGuzman, J.V.; Lamont, R.J.; Yilmaz, O. Genetic transformation of an obligate anaerobe, p. Gingivalis for fmn-green fluorescent protein expression in studying host-microbe interaction. PLoS ONE 2011, 6. [Google Scholar] [CrossRef] [PubMed]
  67. Rodrigues, P.H.; Belanger, M.; Dunn, W., Jr.; Progulske-Fox, A. Porphyromonas gingivalis and the autophagic pathway: An innate immune interaction? Front Biosci. 2008, 13, 178–187. [Google Scholar] [CrossRef] [PubMed]
  68. Gutierrez, M.G.; Mishra, B.B.; Jordao, L.; Elliott, E.; Anes, E.; Griffiths, G. Nf-kappa b activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J. Immunol. 2008, 181, 2651–2663. [Google Scholar] [CrossRef] [PubMed]
  69. Coats, S.R.; Jones, J.W.; Do, C.T.; Braham, P.H.; Bainbridge, B.W.; To, T.T.; Goodlett, D.R.; Ernst, R.K.; Darveau, R.P. Human toll-like receptor 4 responses to p. Gingivalis are regulated by lipid a 1- and 4′-phosphatase activities. Cell Microbiol. 2009, 11, 1587–1599. [Google Scholar] [CrossRef] [PubMed]
  70. Slocum, C.; Coats, S.R.; Hua, N.; Kramer, C.; Papadopoulos, G.; Weinberg, E.O.; Gudino, C.V.; Hamilton, J.A.; Darveau, R.P.; Genco, C.A. Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 2014, 10. [Google Scholar] [CrossRef] [PubMed]
  71. Zenobia, C.; Hajishengallis, G. Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis. Virulence 2015, 6, 236–243. [Google Scholar] [CrossRef] [PubMed]
  72. Zenobia, C.; Hasturk, H.; Nguyen, D.; van Dyke, T.E.; Kantarci, A.; Darveau, R.P. Porphyromonas gingivalis lipid a phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect. Immun. 2014, 82, 650–659. [Google Scholar] [CrossRef] [PubMed]
  73. Martinon, F. Signaling by ros drives inflammasome activation. Eur. J. Immunol. 2010, 40, 616–619. [Google Scholar] [CrossRef] [PubMed]
  74. Trautmann, A. Extracellular atp in the immune system: More than just a “danger signal”. Sci. Signal. 2009, 2. [Google Scholar] [CrossRef] [PubMed]
  75. Di Virgilio, F. Liaisons dangereuses: P2x7 and the inflammasome. Trends Pharmacol. Sci. 2007, 28, 465–472. [Google Scholar] [CrossRef] [PubMed]
  76. Schwiebert, E.M.; Zsembery, A. Extracellular atp as a signaling molecule for epithelial cells. BBA-Biomembranes 2003, 1615, 7–32. [Google Scholar] [CrossRef]
  77. Boots, A.W.; Hristova, M.; Kasahara, D.I.; Haenen, G.R.M.M.; Bast, A.; van der Vliet, A. Atp-mediated activation of the nadph oxidase duox1 mediates airway epithelial responses to bacterial stimuli. J. Biol. Chem. 2009, 284, 17858–17867. [Google Scholar] [CrossRef] [PubMed]
  78. Bucheimer, R.E.; Linden, J. Purinergic regulation of epithelial transport. J. Physiol. 2004, 555, 311–321. [Google Scholar] [CrossRef] [PubMed]
  79. Moore, S.F.; MacKenzie, A.B. Nadph oxidase nox2 mediates rapid cellular oxidation following atp stimulation of endotoxin-primed macrophages. J. Immunol. 2009, 183, 3302–3308. [Google Scholar] [CrossRef] [PubMed]
  80. Coutinho-Silva, R.; Ojcius, D.M. Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites. Microbes Infect. 2012, 14, 1271–1277. [Google Scholar] [CrossRef] [PubMed]
  81. Surprenant, A.; Rassendren, F.; Kawashima, E.; North, R.A.; Buell, G. The cytolytic p2z receptor for extracellular atp identified as a p2x receptor (p2x7). Science 1996, 272, 735–738. [Google Scholar] [CrossRef] [PubMed]
  82. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Hanau, S.; di Virgilio, F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 1997, 185, 579–582. [Google Scholar] [CrossRef] [PubMed]
  83. Morandini, A.C.; Savio, L.E.; Coutinho-Silva, R. The role of p2x7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases. Biomed. J. 2014, 37, 169–177. [Google Scholar] [PubMed]
  84. Spooner, R.; Yilmaz, O. The role of reactive-oxygen-species in microbial persistence and inflammation. Int. J. Mol. Sci. 2011, 12, 334–352. [Google Scholar] [CrossRef] [PubMed]
  85. Biswas, D.; Qureshi, O.S.; Lee, W.Y.; Croudace, J.E.; Mura, M.; Lammas, D.A. Atp-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol. 2008, 9. [Google Scholar] [CrossRef] [PubMed]
  86. Takenouchi, T.; Nakai, M.; Iwamaru, Y.; Sugama, S.; Tsukimoto, M.; Fujita, M.; Wei, J.; Sekigawa, A.; Sato, M.; Kojima, S.; et al. The activation of p2x7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells. J. Immunol. 2009, 182, 2051–2062. [Google Scholar] [CrossRef] [PubMed]
  87. Selvarajan, K.; Moldovan, L.; Chandrakala, A.N.; Litvinov, D.; Parthasarathy, S. Peritoneal macrophages are distinct from monocytes and adherent macrophages. Atherosclerosis 2011, 219, 475–483. [Google Scholar] [CrossRef] [PubMed]
  88. Meissner, F.; Molawi, K.; Zychlinsky, A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 2008, 9, 866–872. [Google Scholar] [CrossRef] [PubMed]
  89. Huang, J.; Canadien, V.; Lam, G.Y.; Steinberg, B.E.; Dinauer, M.C.; Magalhaes, M.A.O.; Glogauer, M.; Grinstein, S.; Brumell, J.H. Activation of antibacterial autophagy by nadph oxidases. Proc. Natl. Acad. Sci. USA 2009, 106, 6226–6231. [Google Scholar] [CrossRef] [PubMed]
  90. Sokolovska, A.; Becker, C.E.; Ip, W.K.E.; Rathinam, V.A.K.; Brudner, M.; Paquette, N.; Tanne, A.; Vanaja, S.K.; Moore, K.J.; Fitzgerald, K.A.; et al. Activation of caspase-1 by the nlrp3 inflammasome regulates the nadph oxidase nox2 to control phagosome function. Nat. Immunol. 2013, 14, 543–553. [Google Scholar] [CrossRef] [PubMed]
  91. Yang, C.S.; Lee, J.S.; Rodgers, M.; Min, C.K.; Lee, J.Y.; Kim, H.J.; Lee, K.H.; Kim, C.J.; Oh, B.; Zandi, E.; et al. Autophagy protein rubicon mediates phagocytic nadph oxidase activation in response to microbial infection or tlr stimulation. Cell Host Microbe 2012, 11, 264–276. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Roberts, J.S.; Yilmaz, Ӧ. Dangerous Liaisons: Caspase-11 and Reactive Oxygen Species Crosstalk in Pathogen Elimination. Int. J. Mol. Sci. 2015, 16, 23337-23354. https://doi.org/10.3390/ijms161023337

AMA Style

Roberts JS, Yilmaz Ӧ. Dangerous Liaisons: Caspase-11 and Reactive Oxygen Species Crosstalk in Pathogen Elimination. International Journal of Molecular Sciences. 2015; 16(10):23337-23354. https://doi.org/10.3390/ijms161023337

Chicago/Turabian Style

Roberts, JoAnn Simone, and Ӧzlem Yilmaz. 2015. "Dangerous Liaisons: Caspase-11 and Reactive Oxygen Species Crosstalk in Pathogen Elimination" International Journal of Molecular Sciences 16, no. 10: 23337-23354. https://doi.org/10.3390/ijms161023337

Article Metrics

Back to TopTop